Recent advances and future perspectives in the management of lung cancer

Current Problems in Surgery

Volumn 42, Issue 8, 2005, Pages 548-610

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; BUDESONIDE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GADOLINIUM; GLUCOCORTICOID; IFOSFAMIDE; IMMUNOMODULATING AGENT; ISOTRETINOIN; MITOMYCIN; NAVELBINE; PACLITAXEL; PLACEBO; PLATINUM DERIVATIVE; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID DERIVATIVE; RETINOL; SELENIUM; TUMOR MARKER; UFT; UNINDEXED DRUG; VINDESINE; ANTINEOPLASTIC AGENT; GEFITINIB; INTERLEUKIN 2; QUINAZOLINE DERIVATIVE;

BIOLOGICAL THERAPY; BONE MARROW METASTASIS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER SCREENING; CANCER STAGING; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SMALL CELL CANCER; LUNG SURGERY; LUNG TRANSPLANTATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM CANCER; MEDIASTINUM LYMPH NODE; MOLECULAR BIOLOGY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; REVIEW; SAMPLING; SENTINEL LYMPH NODE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; FORECASTING; LUNG TUMOR; MASS SCREENING; METHODOLOGY; SENTINEL LYMPH NODE BIOPSY; SMOKING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FORECASTING; HUMANS; INTERLEUKIN-2; LUNG NEOPLASMS; LUNG TRANSPLANTATION; MASS SCREENING; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; QUINAZOLINES; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; SMOKING;

EID: 23744516946     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2005.05.002     Document Type: Note

References (200)

1. A. Jemal R.C. Tiwari T. Murray A. Ghafoor A. Samuels E. Ward et al. Cancer Statistics, 2004 CA Cancer J Clin 54 2004 8-29
2. CDC The health consequences of involuntary smoking: A report of the Surgeon General 1986 US Department of Health and Human Services, Public Health Service Rockville, MD
3. Board on Environmental Studies and Toxicology Committee on Passive Smoking NAoS: Environmental Tobacco Smoke: Measuring Exposure and Assessing Health Effects 1986 National Academic Press Washington DC
4. A.J. Alberg J.M. Samet Epidemiology of lung cancer Chest 123 2003 21S-49S
5. J. Drope S.A. Bialous S.A. Glantz Tobacco industry efforts to present ventilation as an alternative to smoke-free environments in North America Tob Control 13 Suppl 1 2004 i41-i47
6. F.A. Stillman A.M. Hartman B.I. Graubard E.A. Gilpin D.M. Murray J.T. Gibson Evaluation of the American Stop Smoking Intervention Study (ASSIST): A report of outcomes J Natl Cancer Inst 95 22 2003 1681-1691
7. J. Shen L.J. Gudas Molecular cloning of a novel retinoic acid-responsive gene, HA1R-62, which is also up-regulated in Hoxa-1-overexpressing cells Cell Growth Differ 11 2000 11-17
8. L. Olsson O. Behnke H.R. Sorensen Modulatory effects of 5-azacytidine, phorbol ester, and retinoic acid on the malignant phenotype of human lung cancer cells Int J Cancer 35 1985 189-198
9. The Beta Carotene Cancer Prevention Study Group Alpha-tocopherol the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029-1035
10. G.S. Omenn G.E. Goodman M.D. Thornquist J. Balmes M.R. Cullen A. Glass et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 334 1996 1150-1155
11. S.M. Lippman J.J. Lee D.D. Karp E.E. Vokes S.E. Benner G.E. Goodman et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer J Natl Cancer Inst 93 2001 605-618
12. U. Pastorino M. Infante M. Maioli G. Chiesa M. Buyse P. Firket et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A J Clin Oncol 11 1993 1216-1222
13. C.H. Hennekens J.E. Buring J.E. Manson M. Stampfer B. Rosner N.R. Cook et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145-1149
14. N. Saba S. Jain F. Khuri Chemoprevention in lung cancer Curr Prob Cancer 28 2004 287-306
15. G.A. Greeder J.A. Milner Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells Science 209 1980 825-827
16. P. Knekt J. Marniemi L. Teppo M. Heliovaara A. Aromaa Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148 1998 975-982
17. W. Read R. Govindan Recent advances in small cell lung cancer Contemp Oncol 1 2002 1-8
18. S. Lam J.C. LeRiche A. McWilliams C. Macaulay Y. Dyachkova E. Szabo et al. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium Clin Cancer Res 10 2004 6502-6511
19. R.S. Fontana D.R. Sanderson L.B. Woolner W.F. Taylor W.E. Miller J.R. Muhm Lung cancer screening: The Mayo program J Occup Med 28 1986 746-750
20. R.T. Heelan B.J. Flehinger M.R. Melamed M.B. Zaman W.B. Perchick J.F. Caravelli et al. Non-small-cell lung cancer: Results of the New York screening program Radiology 151 1984 289-293
21. C.I. Henschke D.I. McCauley D.F. Yankelevitz D.P. Naidich G. McGuinness O.S. Miettinen et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening Lancet 354 1999 99-105
22. S.J. Swensen J.R. Jett J.A. Sloan D.E. Midthun T.E. Hartman A.M. Sykes et al. Screening for lung cancer with low-dose spiral computed tomography Am J Respir Crit Care Med 165 2002 508-513
23. C.K. Chan C.K. Wells M.J. McFarlane A.R. Feinstein More lung cancer but better survival: Implications of secular trends in "necropsy surprise" rates Chest 96 1989 291-296
24. D.V. Avgerinos J. Bjornsson Malignant neoplasms: Discordance between clinical diagnoses and autopsy findings in 3,118 cases APMIS 109 2001 774-780
25. P.S. Romano D.H. Mark Patient and hospital characteristics related to in-hospital mortality after lung cancer resection Chest 101 1992 1332-1337
26. L. Girard S. Zochbauer-Muller A.K. Virmani A.F. Gazdar J.D. Minna Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering Cancer Res 60 2000 4894-4906
27. G.N. Wogan S.S. Hecht J.S. Felton A.H. Conney L.A. Loeb Environmental and chemical carcinogenesis Semin Cancer Biol 14 2004 473-486
28. E.Y. Woo C.S. Chu T.J. Goletz K. Schlienger H. Yeh G. Coukos et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res 61 2001 4766-4772
29. E.Y. Woo H. Yeh C.S. Chu K. Schlienger R.G. Carroll J.L. Riley et al. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation J Immunol 168 2002 4272-4276
30. C.F. Mountain D.T. Carr W.A. Anderson A system for the clinical staging of lung cancer Am J Roentgenol Radium Ther Nucl Med 120 1974 130-138
31. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710-1717
32. J.J. Erasmus J.E. Connolly H.P. McAdams V.L. Roggli Solitary pulmonary nodules: Part I Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 20 2000 43-58
33. J.W. Gurney Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis part I Theory Radiol 186 1993 405-413
34. C.V. Zwirewich S. Vedal R.R. Miller N.L. Muller Solitary pulmonary nodule: High-resolution CT and radiologic-pathologic correlation Radiology 179 1991 469-476
35. L.E. Quint S. Tummala L.J. Brisson I.R. Francis A.S. Krupnick E.A. Kazerooni et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer Ann Thorac Surg 62 1996 246-250
36. E.M. Toloza L. Harpole D.C. McCrory Noninvasive staging of non-small cell lung cancer: A review of the current evidence Chest 123 1 Suppl 2003 137S-146S
37. R.M. Pieterman J.W. van Putten J.J. Meuzelaar E.L. Mooyaart W. Vaalburg G.H. Koeter et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography N Engl J Med 343 2000 254-261
38. R.J. Cerfolio B. Ojha A.S. Bryant V. Raghuveer J.M. Mountz A.A. Bartolucci The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 2004 1017-1023
39. L.J. Schouten J. Rutten H.A. Huveneers A. Twijnstra Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 2002 2698-2705
40. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer Ann Thorac Surg 71 2001 425-433
41. R. Rosell J. Gomez-Codina C. Camps J. Maestre J. Padille A. Canto et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153-158
42. C. Mountain C. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718-1723
43. E.M. Toloza L. Harpole F. Detterbeck D.C. McCrory Invasive staging of non-small cell lung cancer: A review of the current evidence Chest 123 1 Suppl 2003 157S-166S
44. M.S. Allen G. Darling T. Pechet J.D. Mitcchell J.E. Herndon R.J. Landreneau et al. Morbidity and mortality of major pulmonary resection in patients with early stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 Trial Ann Thorac Surg 2005 (in press)
45. L. Kaiser Atlas of General Thoracic Surgery 1997 Mosby-Year Book St. Louis
46. J. Deslauriers A. Aucoin J. Gregoire Postpneumonectomy pulmonary edema Chest Surg Clin N Am 8 1998 611-631 ix
47. H.F. Lausberg T.P. Graeter O. Wendler D. Tscholl H.J. Schafers Bronchovascular Sleeve Resections for Central Lung Tumors 2004 Society of Thoracic Surgeons San Antonio, TX
48. M. Okada H. Yamagishi S. Satake H. Matsuoka Y. Miyamoto M. Yoshimura et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy J Thorac Cardiovasc Surg 119 4 Pt 1 2000 814-819
49. K. Kawahara S. Akamine T. Takahashi A. Nakamura M. Muraoka H. Tsuji et al. Management of anastomotic complications after sleeve lobectomy for lung cancer Ann Thorac Surg 57 1994 1529-1532
50. J.B. Shrager E.S. Lambright C.M. McGrath P.M. Wahl M.E. Deeb J.S. Friedberg et al. Lobectomy with tangential pulmonary artery resection without regard to pulmonary function Ann Thorac Surg 70 2000 234-239
51. T. Naruke T. Goya R. Tsuchiya K. Suemasu The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis Ann Thorac Surg 46 1988 603-610
52. A. Gajra N. Newman G.P. Gamble L.J. Kohman S.L. Graziano Effect of number of lymph nodes sampled on outcome in patients with stage i non-small-cell lung cancer J Clin Oncol 21 2003 1029-1034
53. J.R. Izbicki O. Thetter M. Habekost O. Karg B. Passlick B. Kubuschok et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: A randomized controlled trial Br J Surg 81 1994 229-235
54. J.R. Izbicki B. Passlick K. Pantel U. Pichlmeier S.B. Hosch O. Karg et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: Results of a prospective randomized trial Ann Surg 227 1998 138-144
55. J. D'Cunha A.L. Corfits I. Herndon E. James J.A. Kern L.J. Kohman G.A. Patterson et al. Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer - preliminary results of cancer and leukemia group B trial 9761 J Thorac Cardiovasc Surg 123 2002 484-491
56. C.L. Lau M.B. Moore K.R. Brooks T.A. D'Amico D.H. Harpole Jr. Molecular staging of lung and esophageal cancer Surg Clin North Am 82 2002 497-523
57. M.J. Liptay S.C. Grondin W.A. Fry C. Pozdol D. Carson C. Knop et al. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases J Clin Oncol 20 2002 1984-1988
58. G. Silvestri J. Handy D. Lackland E. Corley C. Reed Specialists achieve better outcomes than generalists for lung cancer surgery Chest 114 1998 675-680
59. T. Kirby T. Rice Thoracoscopic lobectomy Ann Thorac Surg 56 1993 784-786
60. T.J. Kirby M.J. Mack R.J. Landreneau T.W. Rice Lobectomy - video-assisted thoracic surgery versus muscle-sparing thoracotomy: A randomized trial J Thorac Cardiovasc Surg 109 1995 997-1001
61. L.J. Daniels S.S. Balderson M.W. Onaitis T.A. D'Amico Thoracoscopic lobectomy: A safe and effective strategy for patients with stage I lung cancer Ann Thorac Surg 74 2002 860-864
62. H. Nomori H. Horio T. Naruke K. Suemasu What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery? Ann Thorac Surg 72 2001 879-884
63. I. Nagahiro A. Andou M. Aoe Y. Sano H. Date N. Shimizu Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure Ann Thorac Surg 72 2001 362-365
64. R.J. McKenna Jr R.K. Wolf M. Brenner R.J. Fischel P. Wurnig Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Ann Thorac Surg 66 1998 1903-1908
65. R.J. Lewis R.J. Caccavale J.P. Bocage M.D. Widmann Video-assisted thoracic surgical non-rib spreading simultaneously stapled lobectomy: A more patient-friendly oncologic resection Chest 116 1999 1119-1124
66. A.P.C. Yim VATS major pulmonary resection revisited - controversies, techniques, and results Ann Thorac Surg 74 2002 615-623
67. J. Nakajima S. Takamoto T. Kohno T. Ohtsuka Costs of videothoracoscopic surgery versus open resection for patients with of lung carcinoma Cancer 89 11 Suppl 2000 2497-2501
68. R.J. Landreneau D.J. Sugarbaker M.J. Mack S.R. Hazelrigg J.D. Luketich L. Fetterman et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer J Thorac Cardiovasc Surg 113 1997 691-698 discussion 622-3
69. R.J. Ginsberg L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer: Lung Cancer Study Group Ann Thorac Surg 60 1995 615-622
70. T.A. d'Amato M. Galloway G. Szydlowski A. Chen R.J. Landreneau Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer Chest 114 1998 1112-1115
71. R. Santos A. Colonias D. Parda M. Trombetta R.H. Maley R. Macherey et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer Surgery 134 2003 691-697
72. B. Decadt A.K. Siriwardena Radiofrequency ablation of liver tumours: systematic review Lancet Oncol 5 2004 550-560
73. S.N. Goldberg G.S. Gazelle C.C. Compton T.C. McLoud Radiofrequency tissue ablation in the rabbit lung: Efficacy and complications Acad Radiol 2 1995 776-784
74. Y. Miao Y. Ni H. Bosmans J. Yu J. Vaninbroukx S. Dymarkowski et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits J Surg Res 99 2001 265-271
75. D.E. Dupuy R.J. Zagoria W. Akerley W.W. Mayo-Smith P.V. Kavanagh H. Safran Percutaneous radiofrequency ablation of malignancies in the lung AJR Am J Roentgenol 174 2000 57-59
76. K. Steinke J.M. Habicht S. Thomsen M. Soler A.L. Jacob CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection Cardiovasc Intervent Radiol 25 2002 543-546
77. C. Gadaleta V. Mattioli G. Colucci A. Cramarossa V. Lorusso E. Canniello et al. Radiofrequency ablation of 40 lung neoplasms: Preliminary results AJR Am J Roentgenol 183 2004 361-368
78. K. Steinke P.E. Sewell D. Dupuy R. Lencioni T. Helmberger S.T. Kee et al. Pulmonary radiofrequency ablation: An international study survey Anticancer Res 24 2004 339-343
79. C. Geltner H. Jamnig B. Bucher D. Tomazzan L. Muller Lung transplantation for bronchioalveolar carcinoma Lung Cancer 37 2002 S27
80. B. Etienne M. Bertocchi J.P. Gamondes T. Wiesendanger J. Brune J.F. Mornex Successful double-lung transplantation for bronchioalveolar carcinoma Chest 112 1997 1423-1424
81. E.B. Paloyan L.J. Swinnen A. Montoya V. Lonchyna H.J. Sullivan E. Garrity Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs Transplantation 69 2000 2446-2448
82. M. de Perrot S. Chernenko T.K. Waddell Y. Shargall A.F. Pierre M. Hutcheon et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease J Clin Oncol 22 2004 4351-4356
83. W. Fox J.G. Scadding Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus: Ten-year follow-up Lancet 2 1973 63-65
84. C.F. Mountain Clinical biology of small cell carcinoma: Relationship to surgical therapy Semin Oncol 5 1978 272-279
85. S.S. Shah J. Thompson P. Goldstraw Results of operation without adjuvant therapy in the treatment of small cell lung cancer Ann Thorac Surg 54 1992 498-501
86. L. Coolen A. Van den Eeckhout G. Deneffe M. Demedts J. Vansteenkiste Surgical treatment of small cell lung cancer Eur J Cardiothorac Surg 9 1995 59-64
87. F.A. Shepherd R.J. Ginsberg G.A. Patterson W.K. Evans R. Feld A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer: A University of Toronto Lung Oncology Group study J Thorac Cardiovasc Surg 97 1989 177-186
88. F.A. Shepherd R. Ginsberg G.A. Patterson R. Feld P.E. Goss F.G. Pearson et al. Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg 101 1991 196-200
89. E.C. Holmes M. Gail Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma J Clin Oncol 4 1986 710-715
90. M. Ohta R. Tsuchiya M. Shimoyama K. Sawamura T. Mori N. Miyazawa et al. The Japan Clinical Oncology Group Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer: Results of a randomized prospective study J Thorac Cardiovasc Surg 106 1993 703-708
91. Anonymous Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials (see comments) BMJ 311 1995 899-909
92. G. Strauss M.A. Maddaus E.A. Johnson J. Herndon D.W. Johnstone D. Watson et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB NSCLC ASCO Meeting Abstracts Proc Am Soc Clin Oncol 2004 (abs #7019)
93. R. Arriagada B. Bergman A. Dunant et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351-360
94. T.L. Winton R. Livingston D. Johnson J.R. Rigas Y. Cormier C. Butts et al. A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non small cell lung cancer (NSCLC) Intergroup JBR. ASCO Meeting Abstracts. 10 Proc Am Soc Clin Oncol 2004 (abs #7018)
95. H. Wada S. Hitomi T. Teramatsu Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery J Clin Oncol 14 1996 1048-1054
96. K. Kelly J. Crowley P.A. Bunn Jr C.A. Presant P.K. Grevstad C.M. Moinpour et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial J Clin Oncol 19 2001 3210-3218
97. F. Fossella J.R. Pereira J. Von Pawel A. Pluzanska V. Gorbounova E. Kaukel et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study Group J Clin Oncol 21 2003 3016-3024
98. C.P. Belani C. Langer First-line chemotherapy for NSCLC: An overview of relevant trials Lung Cancer 38 1 Suppl 2002 13-19
99. M.A. Socinski M.J. Schell A. Peterman K. Bakri S. Yates R. Gitten et al. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer J Clin Oncol 20 2002 1335-1343
100. F.A. Shepherd J. Dancey A. Arnold A. Neville J. Rusthoven R.D. Johnson et al. Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: A study of the National Cancer Institute of Canada Clinical Trials Group Cancer 92 2001 595-600
101. F.V. Fossella R. DeVore R.N. Kerr J. Crawford R.R. Natale F. Dunphy et al. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group J Clin Oncol 18 12 2000 2354-2362
102. F.A. Shepherd J. Pereira T.E. Ciuleanu E.H. Tan V. Hirsh S. Thongprasert et al. A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy: A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial. ASCO Meeting Abstacts J Clin Oncol 2004 (abs #7022)
103. H. Nakhashi K. Yasumoto T. Ishida Results of surgical treatment of patients with T3 non-small cell lung cancer Ann Thorac Surg 46 1988 178-181
104. T.F. Nealon Choice of operation and technique for cancer of the lung. Proceedings of the Sixth National Cancer Conference 1970 JB Lippincott Philadelphia
105. F.G. Bloedorn R.A. Cowley Irradiation and surgery in the treatment of bronchogenic carcinoma Surg Gynecol Obstet 111 1960 141-146
106. J. Warram Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial: A collaborative study Cancer 36 1975 914-925
107. T.W. Shields Preoperative radiation therapy in the treatment of bronchial carcinoma Cancer 30 1972 1388-1394
108. A. Trakhtenerg E. Kiseleva V. Pitskhelauri Preoperative radiotherapy in the combined treatment of lung cancer patients Neoplasma 35 1988 459-465
109. K.S. Albain V.W. Rusch J.J. Crowley T.W. Rice A.T. Turrisi 3rd J.K. Weick et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880-1892
110. K.S. Albain C. Scott V. Rusch et al. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (Pn2) non-small cell lung cancer (NSCLC): initial results from Intergroup Trial 0139 (RTOG 93-01). ASCO Meeting Abstracts J Clin Oncol 2003 (abs #2497)
111. M. Thomas H.N. Macha D. Ukena M. Hamm M. Deppermann M. Semik et al. Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/ CT) versus PE alone before surgery in stage III non-small cell lung cancer (NSCLC): A randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG) Proc Am Soc Clin Oncol 2004 22[14S(July 15 Suppl)]. (abs #7004)
112. B. Dautzenberg R. Arriagada A.B. Chammard A. Jarema M. Mezzetti K. Mattson et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques Cancer 86 1999 265-273
113. S.M. Keller Adjuvant therapy of resected non-small-cell lung cancer Curr Opin Oncol 12 2000 149-155
114. Group PORT Meta-analysis Trialist Group Postoperative radiotherapy in nonsmall cell lung cancer systematic review and meta-analysis of individual patient data from nine randomised clinical trials Lancet 352 1998 257-263
115. P. van Houtte P. Rocmans P. Smets J.-C. Goffin J. Lustman-Marechal P. Vanderhoeft et al. Postoperative radiotherapy in lung cancer: A controlled trial after resection of curative design Int J Radiat Oncol Biol Phys 6 1980 983-986
116. B. Emami L. Kaiser J. Simpson S. Shapiro C. Roper M.A. Lockett Postoperative radiation therapy in non-small cell lung cancer Am J Clin Oncol 20 1997 441-448
117. N.C. Choi H.C. Grillo M. Gardiello J.G. Scannell E.W. Wilkins Jr. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma Int J Radiat Oncol Biol Phys 6 1980 31-35
118. N. Martini M.S. Bains M.E. Burt M.F. Zakowski P. McCormack V.W. Rusch et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120-129
119. R.C. McGarry G. Song P. des Rosiers R. Timmerman Observation-only management of early stage, medically inoperable lung cancer: Poor outcome Chest 121 2002 1155-1158
120. B.G. Haffty N.B. Goldberg J. Gerstley D.B. Fischer R.E. Peschel Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer Int J Radiat Oncol Biol Phys 15 1988 69-73
121. J.G. Armstrong B.D. Minsky Radiation therapy for medically inoperable stage I and II non-small cell lung cancer Cancer Treat Rev 16 1989 247-255
122. J.D. Bradley S. Wahab M.A. Lockett C.A. Perez J.A. Purdy Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields Int J Radiat Oncol Biol Phys 56 2003 342-347
123. R. Arriagada B. Pellae-Cosset J. Cueto Ladron de Guevara Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: Analysis of local chest recurrences Radiother Oncol 20 1991 91-98
124. M.K. Martel W.M. Sahijdak J.A. Hayman D. Ball Incidental doses to clinically negative nodes from conformal treatment fields for non-small cell lung cancer Int J Radiat Oncol Biol Phys 45 3 Suppl 1999 244
125. R. Rengan K.E. Rosenzweig E. Venkatraman L.A. Koutcher J.L. Fox R. Nayak et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 60 2004 741-747
126. S. Narayan G.T. Henning R.K. Ten Haken M.A. Sullivan M.K. Martel J.A. Hayman Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer Lung Cancer 44 2004 79-88
127. W.J. Curran Jr P.J. Moldofsky L.J. Solin Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function Cancer 65 1990 2488-2493
128. H.X. Zhang W.B. Yin L.J. Zhang Z.Y. Yang Z.X. Zhang M. Wang et al. Curative radiotherapy of early operable non-small cell lung cancer Radiother Oncol 14 1989 89-94
129. A.D. Krol P. Aussems E.M. Noordijk J. Hermans J.W. Leer Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34 1996 297-302
130. K.E. Rosenzweig S.E. Sim B. Mychalczak L.E. Braban R. Schindelheim S.A. Leibel Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 50 2001 681-685
131. J. Bradley M.V. Graham K. Winter J.A. Purdy R. Komaki W.H. Roa et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318-328
132. J.D. Bradley C.A. Perez F. Dehdashti B.A. Siegel Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer J Nucl Med 1 45 Suppl 2004 96S-101S
133. E. Alexander 3rd T.M. Moriarty R.B. Davis P.Y. Wen H.A. Fine P.M. Black et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases J Natl Cancer Inst 87 1995 34-40
134. J.C. Flickinger D. Kondziolka L.D. Lunsford R.J. Coffey M.L. Goodman E.G. Shaw et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis Int J Radiat Oncol Biol Phys 28 1994 797-802
135. D.A. Low M. Nystrom E. Kalinin P. Parikh J.F. Dempsey J.D. Bradley et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing Med Phys 30 2003 1254-1263
136. M. Uematsu A. Shioda K. Tahara T. Fukui F. Yamamoto G. Tsumatori et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience Cancer 82 1998 1062-1070
137. H. Onishi K. Kuriyama T. Komiyama S. Tanaka N. Sano K. Marino et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: Patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner Lung Cancer 45 2004 45-55
138. Y. Nagata Y. Negoro T. Aoki T. Mizowaki K. Takayama M. Kokubo et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 52 2002 1041-1046
139. R. Timmerman L. Papiez R. McGarry L. Likes C. DesRosiers S. Frost et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946-1955
140. M. Hiraoka Y. Nagata Stereotactic body radiation therapy for early-stage non-small-cell lung cancer the Japanese experience Int J Clin Oncol 9 2004 352-355
141. M. Fuss B.J. Salter P. Rassiah D. Cheek S.X. Cavanaugh T.S. Herman Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy Technol Cancer Res Treat 3 2004 59-67
142. R.I. Whyte R. Crownover M.J. Murphy D.P. Martin T.W. Rice M.M. DeCamp Jr et al. Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial Ann Thorac Surg 75 2003 1097-1101
143. C.A. Perez K. Stanley P. Rubin S. Kramer L. Brady R. Perez-Tamayo et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group Cancer 45 1980 2744-2753
144. R.O. Dillman S.L. Seagren K.J. Propert J. Guerra W.L. Eaton M.C. Perry et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940-945
145. R.O. Dillman J. Herndon S.L. Seagren W.L. Eaton Jr M.R. Green Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210-1215
146. W. Sause P. Kolesar S.I. Taylor D. Johnson R. Livingston R. Komaki et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358-364
147. T. Le Chevalier R. Arriagada E. Quoix P. Ruffie M. Martin M. Tarayre et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417-423
148. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 1995 899-909
149. E. Soresi M. Clerici R. Grilli U. Borghini R. Zucali M. Leoni et al. A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer Semin Oncol 15 6 Suppl 7 1988 20-25
150. C. Blanke R. Ansari R. Mantravadi R. Gonin R. Tokars W. Fisher et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol J Clin Oncol 13 1995 1425-1429
151. C. Schaake-Koning W. Van den Bogaert O. Dalesio J. Fister J. Hoogenhaut P. VanHoutte et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524-530
152. B. Jeremic Y. Shibamoto L. Acimovic S. Milisavljevic Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small-cell lung cancer: A randomized study J Clin Oncol 14 1996 1065-1070
153. B. Jeremic Y. Shibamoto L. Acimovic L. Djuric Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 1995 452-458
154. J.S. Lee R. Komaki F.V. Fossella B.S. Glisson W.K. Hong J.D. Cox A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: A 5-year follow-up report Int J Radiat Oncol Biol Phys 42 1998 479-486
155. K. Furuse M. Fukuoka M. Kawahara H. Nishikawa Y. Takada S. Kudoh et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692-2699
156. W. Curran Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. ASCO Meeting Abstract Proc Am Soc Clin Oncol 22 2003 621
157. F. Pierre P. Maurice R. Gilles et al. A randomized phase III trial of sequential chemoradiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (GLOT-GFPC NPC 95-01 study) Asco Meeting Abstract Proc Am Soc Clin Oncol 20 2001 312a
158. H. Choy W. Curran C. Scott P. Bonomi P. Travis J. Haluchak et al. Preliminary report of locally advanced multimodality protocol (LAMP): ACR 427: A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and thoracic radiation (TRT) for patients with locally advanced non small cell lung cancer (LA-NSCLC). ASCO Meeting Abstract Proc Am Soc Clin Oncol 2002 (abs #1160)
159. K.S. Albain J.J. Crowley A.T. Turrisi 3rd D.R. Gandara W.B. Farrar J.I.
160. E.E. Vokes J.E. Herndon 2nd J. Crawford K.A. Leopold M.C. Perry A.A. Miller et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431 J Clin Oncol 20 2002 4191-4198
161. S. Hirota K. Tsujino M. Endo Y. Kotani M. Satouchi T. Kado et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy Int J Radiat Oncol Biol Phys 51 2001 291-295
162. A. Bezjak P. Dixon M. Brundage D. Tu M.J. Palmer P. Blood et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15) Int J Radiat Oncol Biol Phys 54 2002 719-728
163. U. Nestle C. Nieder K. Walter U. Abel D. Ukena G.W. Sybrecht et al. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: Results of a randomized equivalence study Int J Radiat Oncol Biol Phys 48 2000 95-103
164. S. Sundstrom R. Bremnes U. Aasebo S. Aamdal R. Hatlevoll P. Brunsvig et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial J Clin Oncol 22 2004 801-810
165. B. Jeremic Y. Shibamoto L. Acimovic B. Milicic S. Milisavljevic N. Nikolic et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain Int J Radiat Oncol Biol Phys 42 1998 161-167
166. J. Bedwinek A. Petty C. Bruton J. Sofield L. Lee The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma Int J Radiat Oncol Biol Phys 22 1992 23-30
167. J.A. Escobar-Sacristan J.I. Granda-Orive T. Gutierrez Jimenez J.M. Delgado A. Rodero Banos R. Saez Valls Endobronchial brachytherapy in the treatment of malignant lung tumours Eur Respir J 24 2004 348-352
168. P. Muto V. Ravo G. Panelli G. Liguori G. Fraioli High-dose rate brachytherapy of bronchial cancer: Treatment optimization using three schemes of therapy Oncologist 5 2000 209-214
169. D. Nori R. Allison B. Kaplan E. Samala A. Osian S. Karbowitz High dose-rate intraluminal irradiation in bronchogenic carcinoma Technique and results. Chest 104 1993 1006-1011
170. J.S. Ross D.P. Schenkein R. Pietrusko M. Rolfe G.P. Linette J. Stec et al. Targeted therapies for cancer 2004 Am J Clin Pathol 122 2004 598-609
171. B.B. Tysnes H.K. Haugland R. Bjerkvig Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas Invasion Metastasis 17 1997 270-280
172. T. Akimoto N.R. Hunter L. Buchmiller K. Mason K.K. Ang L. Milas Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas Clin Cancer Res 5 1999 2884-2890
173. B.R. Voldborg L. Damstrup M. Spang-Thomsen H.S. Poulsen Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials Ann Oncol 8 1997 1197-1206
174. V. Rusch J. Baselga C. Cordon-Cardo J. Orazem M. Zaman S. Hoda et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung Cancer Res 53 10 Suppl 1993 2379-2385
175. C.L. Arteaga Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia Semin Oncol 29 5 Suppl 14 2002 3-9
176. S. Merluzzi M. Figini A. Colombatti S. Canevari C. Pucillo Humanized antibodies as potential drugs for therapeutic use Adv Clin Pathol 4 2000 77-85
177. F.A. Al-Obeidi K.S. Lam Development of inhibitors for protein tyrosine kinases Oncogene 19 2000 5690-5701
178. F.M. Sirotnak M.F. Zakowski V.A. Miller H.I. Scher M.G. Kris Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase Clin Cancer Res 6 2000 4885-4892
179. M. Ranson L.A. Hammond D. Ferry M. Kris A. Tullo P.I. Murray et al. ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: Results of a phase I trial J Clin Oncol 20 2002 2240-2250
180. R.S. Herbst A.M. Maddox M.L. Rothenberg E.J. Small E.H. Rubin J. Baselga et al. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: Results of a phase I trial J Clin Oncol 20 2002 3815-3825
181. M. Fukuoka S. Yano G. Giaccone T. Tamura K. Nakagawa J.Y. Douillard et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 2003 2237-2246
182. M.G. Kris R.B. Natale R.S. Herbst T.J. Lynch Jr D. Prager C.P. Belani et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial JAMA 290 2003 2149-2158
183. F.V. Fossella J.S. Lee W.K. Hong Management strategies for recurrent non-small cell lung cancer Semin Oncol 24 1997 455-462
184. F.R. Hirsch M. Varella-Garcia P.A. Bunn Jr M.V. Di Maria R. Veve R.M. Bremmes et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 2003 3798-3807
185. P.A. Janne S. Gurubhagavatula B.Y. Yeap J. Lucca P. Ostler A.T. Skarin et al. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study Lung Cancer 44 2004 221-230
186. V.A. Miller M.G. Kris N. Shah J. Patel C. Azzoli J. Gomez et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer J Clin Oncol 22 2004 1103-1109
187. G. Giaccone R.S. Herbst C. Manegold G. Scagliotti R. Rosell V. Miller et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT 1 J Clin Oncol 22 2004 777-784
188. R.S. Herbst G. Giaccone J.H. Schiller R.B. Natale V. Miller C. Manegold et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT 2 J Clin Oncol 22 2004 785-794
189. J.G. Paez P.A. Janne J.C. Lee S. Tracy H. Greulich S. Gabriel et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 304 2004 1497-1500
190. T.J. Lynch D.W. Bell R. Sordella S. Gurubhagavatula R.A. Okimoto B.W. Brannigan et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129-2139
191. M.F. McKneally C. Maver H.W. Kausel Regional immunotherapy of lung cancer with intrapleural B.C.G Lancet 1 1976 377-379
192. M.H. Gail A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771 Chest 106 6 Suppl 1994 287S-292S
193. P. Lissoni S. Meregalli V. Fossati F. Paolorossi S. Barni G. Tancini et al. A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer Tumori 80 1994 464-467
194. H. Takita A.C. Hollinshead R.H. Adler J. Bhayana M. Ramundo R. Moskowitz et al. Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma: A 5-year survival analysis J Surg Oncol 46 1991 9-14
195. G. Buccheri D. Ferrigno Lung cancer: Clinical presentation and specialist referral time Eur Respir J 24 2004 898-904
196. J.R. Jett D.E. Midthun Screening for lung cancer: Current status and future directions: Thomas A. Neff lecture Chest 125 5 Suppl 2004 158S-162S
197. S.J. Swensen J.R. Jett T.E. Hartman D.E. Midthun J.A. Sloan A.M. Sykes et al. Lung cancer screening with CT: Mayo Clinic experience Radiology 226 2003 756-761
198. R.F. Morton J.R. Jett W.L. McGinnis J.D. Earle T.M. Therneau J.E. Krook et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: A randomized, phase III trial Ann Intern Med 115 1991 681-686
199. W.T. Sause R.W. Byhardt W.J. Curran Jr D. Fuller M.V. Graham B. Ko et al. Follow-up of non-small cell lung cancer American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl 2000 1363-1372
200. E.A. Rendina F. Venuta T. de Giacomo M. Rossi G.F. Coloni Parenchymal sparing operation for bronchogenic carcinoma Surg Clin North Am 82 2002 589-609 vii